Trial intelligence / Profile preview

Dysport vs Botox in Cervical Dystonia

NCT00950664Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Aug 2009
Primary completion
Jan 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of botulinum toxin type A in cervical dystonia (CD), sponsored by Seoul National University Hospital. Primary endpoint: Tsui Score at 4 weeks. Started Aug 2009; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

cervical dystonia (CD)

Beyond the preview

Go deeper on NCT00950664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00950664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call